This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slid 1.88% to $6.80 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.41% to 4,363.55 and the Dow Jones Industrial Average rising 0.30% to 34,416.99. Ocugen Inc. closed $11.97 short of its 52-week high ($18.77), which the company reached on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. (ADVM) fell 5.09% to $2.05, Ocular Therapeutix Inc. (OCUL) rose 1.64% to $9.90, and Kodiak Sciences Inc. (KOD) rose 0.97% to $101.13. Trading volume (7.6 M) remained 4.9 million below its 50-day average volume of 12.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2021.
(END) Dow Jones Newswires
October 06, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.